Universal Vision Biotechnology Co., Ltd.

TPEX:3218 Stock Report

Market Cap: NT$21.7b

Universal Vision Biotechnology Balance Sheet Health

Financial Health criteria checks 6/6

Universal Vision Biotechnology has a total shareholder equity of NT$3.3B and total debt of NT$10.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are NT$5.1B and NT$1.8B respectively. Universal Vision Biotechnology's EBIT is NT$1.3B making its interest coverage ratio -393.6. It has cash and short-term investments of NT$1.6B.

Key information

0.3%

Debt to equity ratio

NT$9.97m

Debt

Interest coverage ratio-393.6x
CashNT$1.64b
EquityNT$3.34b
Total liabilitiesNT$1.79b
Total assetsNT$5.13b

Recent financial health updates

Recent updates

Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 03
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?

Mar 26
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?

Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate

Mar 08
Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate

The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention

Feb 07
The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention

Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Jan 17
Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly

Dec 27
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)

Dec 06
Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)

Financial Position Analysis

Short Term Liabilities: 3218's short term assets (NT$2.6B) exceed its short term liabilities (NT$1.0B).

Long Term Liabilities: 3218's short term assets (NT$2.6B) exceed its long term liabilities (NT$764.5M).


Debt to Equity History and Analysis

Debt Level: 3218 has more cash than its total debt.

Reducing Debt: 3218's debt to equity ratio has reduced from 9.5% to 0.3% over the past 5 years.

Debt Coverage: 3218's debt is well covered by operating cash flow (15581.1%).

Interest Coverage: 3218 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.